A1C test not accurate for diabetics on dialysis

NEW YORK -- The A1C test, the usual way of measuring long-range diabetes control, is not reliable for people who are undergoing hemodialysis, a new study shows. “These results suggest that the nearly 200,000 diabetic hemodialysis patients in the U.S. who use this test may not be receiving optimal care for their blood sugar,” Dr. Barry I. Freedman, from Wake Forest University School of Medicine in Winston-Salem, North Carolina, said in a statement.

The A1C test measures how much of the hemoglobin in a person’s blood is “glycated” — has glucose attached to it — and it reflects the level of glucose circulating over the long term. Glycated hemoglobin is designated HbA1c, or just A1C.

 

 

 

 

 

 

 

 

Subscribe to The China Post and save.  Click hereSharePrintEmail
Write a Comment



CAPTCHA Code Image
Change the code
 Receive China Post promos Respond to this email
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Guide  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   English Courses  |   Terms of Use  |   Sitemap